These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 35973789)

  • 1. ENDS advertising expenditures in English language media in the USA, 2015-2020.
    Welding K; Marynak KL; Trigger S; Kelley D; Jewler L; Kennedy RD
    Tob Control; 2023 Dec; 33(1):122-125. PubMed ID: 35973789
    [TBL] [Abstract][Full Text] [Related]  

  • 2. E-cigarette advertising expenditures in the USA, 2014-2018.
    Ali FRM; Marynak KL; Kim Y; Binns S; Emery SL; Gomez Y; King BA
    Tob Control; 2020 Dec; 29(e1):e124-e126. PubMed ID: 32108086
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Promoting corporate image or preventing underage use? Analysis of the advertising strategy and expenditures of the JUUL parent education for youth vaping prevention campaign.
    Kostygina G; Szczypka G; Czaplicki L; Borowiecki M; Ahn R; Schillo B; Emery SL
    Tob Control; 2022 Sep; 31(5):655-658. PubMed ID: 34059551
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Electronic nicotine delivery system advertising in business-to-business publications, United States, 2015-2020.
    Marynak K; Welding K; Kelley D; Trigger S; Moran MB; Kennedy RD
    Drug Alcohol Rev; 2023 Feb; 42(2):262-267. PubMed ID: 36269112
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterising advertising strategies and expenditures for conventional and newer smokeless tobacco products.
    Emery SL; Binns S; Carter CC; Rose SW; Kostygina G
    Tob Control; 2023 Nov; 32(6):795-798. PubMed ID: 35803674
    [TBL] [Abstract][Full Text] [Related]  

  • 6. E-cigarette Marketing Expenditures in the United States From 2016 to 2021: Targeted Media Outlets Geared Toward People Who Are at Increased Risk for Tobacco Use.
    Ozga JE; Stroup AM; Abadi MH; Cheney MK; Majmundar A; Garrison KA; Chen-Sankey J; Shamblen S; Dunlap C; Stanton CA
    Nicotine Tob Res; 2023 Feb; 25(3):581-585. PubMed ID: 36070398
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nicotine pouch marketing strategies in the USA: an analysis of Zyn, On! and Velo.
    Duan Z; Henriksen L; Vallone D; Rath JM; Evans WD; Romm KF; Wysota C; Berg CJ
    Tob Control; 2024 Feb; 33(2):154-163. PubMed ID: 35817549
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oral nicotine product marketing expenditures in the USA from 2016 to 2023: trends over time by brand and targeted media outlets.
    Ozga JE; Cornacchione Ross J; Hrywna M; Sharma A; Ling PM; Stanton CA
    Tob Control; 2024 Mar; ():. PubMed ID: 38485232
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Food and beverage advertising expenditures in Canada in 2016 and 2019 across media.
    Potvin Kent M; Pauzé E; Bagnato M; Guimarães JS; Pinto A; Remedios L; Pritchard M; L'Abbé MR; Mulligan C; Vergeer L; Weippert M
    BMC Public Health; 2022 Aug; 22(1):1458. PubMed ID: 35915428
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exposure to e-cigarette TV advertisements among U.S. youth and adults, 2013-2019.
    Duan Z; Wang Y; Emery SL; Chaloupka FJ; Kim Y; Huang J
    PLoS One; 2021; 16(5):e0251203. PubMed ID: 33961669
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nicotine-related content in English language ENDS advertisements in the US: 2018-2020.
    Kennedy RD; Moran M; Czaplicki L; Handy J; Welding K; Kelley D
    Prev Med; 2023 Jun; 171():107513. PubMed ID: 37054990
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Presence of Nicotine Warning Statement on US Electronic Nicotine Delivery Systems (ENDS) Advertisements 6 Months Before and After the August 10, 2018 Effective Date.
    Czaplicki L; Marynak K; Kelley D; Moran MB; Trigger S; Kennedy RD
    Nicotine Tob Res; 2022 Oct; 24(11):1720-1726. PubMed ID: 35486959
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IQOS marketing strategies in the USA before and after US FDA modified risk tobacco product authorisation.
    Berg CJ; Romm KF; Bar-Zeev Y; Abroms LC; Klinkhammer K; Wysota CN; Khayat A; Broniatowski DA; Levine H
    Tob Control; 2023 Jul; 32(4):418-427. PubMed ID: 34667105
    [TBL] [Abstract][Full Text] [Related]  

  • 14. E-cigarette advertising expenditures in the U.S., 2011-2012.
    Kim AE; Arnold KY; Makarenko O
    Am J Prev Med; 2014 Apr; 46(4):409-12. PubMed ID: 24650844
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of Brand Engagement Appeals in US Cigarette and E-Cigarettes Ads (2019-2020).
    Czaplicki L; Patel D; Jewler K; Moran MB
    Subst Use Misuse; 2024; 59(6):832-839. PubMed ID: 38247155
    [No Abstract]   [Full Text] [Related]  

  • 16. Flavored electronic nicotine delivery systems ads (2019-2020) on traditional U.S. Media by audience demographics.
    Czaplicki L; Duren M; Kelley D; Moran MB; Welding K; Kennedy RD
    Prev Med Rep; 2023 Oct; 35():102346. PubMed ID: 37576840
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Youth-appealing features in popular e-cigarette brand advertising in the USA after heightened scrutiny in 2018.
    Liu J; Vázquez-Otero C; Berman ML; Stevens EM
    Tob Control; 2023 Jul; 32(4):497-500. PubMed ID: 34675113
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Presence of flavoured electronic nicotine delivery system (ENDS) products in US ENDS advertisements, 2015-2020: a content analysis.
    Moran MB; Czaplicki L; Tadesse L; Handy J; Welding K; Kelley D; Kennedy RD
    BMJ Open; 2023 Jun; 13(6):e070212. PubMed ID: 37385739
    [TBL] [Abstract][Full Text] [Related]  

  • 19. How the industry is marketing menthol cigarettes: the audience, the message and the medium.
    Richardson A; Ganz O; Pearson J; Celcis N; Vallone D; Villanti AC
    Tob Control; 2015 Nov; 24(6):594-600. PubMed ID: 25178275
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vaping versus JUULing: how the extraordinary growth and marketing of JUUL transformed the US retail e-cigarette market.
    Huang J; Duan Z; Kwok J; Binns S; Vera LE; Kim Y; Szczypka G; Emery SL
    Tob Control; 2019 Mar; 28(2):146-151. PubMed ID: 29853561
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.